Literature DB >> 22312702

Formulation of PEG-ylated L-asparaginase loaded poly (lactide-co-glycolide) nanoparticles: influence of Pegylation on enzyme loading, activity and in vitro release.

S Suri Vasudev1, S Ahmad, R Parveen, F J Ahmad, C K Anish, M Ali, A K Panda.   

Abstract

The present paper describes the advantage of PEG-ylation of L-asparaginase before encapsulation over its incorporation in the native form. During encapsulation a considerable amount of native protein undergoes denaturation and forms insoluble aggregates. In an effort to overcome this problem, L-asparaginase was PEG-ylated before subjecting it to the harsh conditions as encountered during double emulsion solvent evaporation technique. L-asparaginase was conjugated with succinimidyl succinate derivative of polyethylene glycol (SS-PEG, MW 5000) followed by characterization of the formed conjugate using size exclusion-HPLC and SDS PAGE. The PEG-ylated L-asparaginase consisted of different isomers from mono to multi PEG-ylated depending upon the number of Lysine residues (14 in case of L-asparaginase) with about 5% as native protein. The specific activity as retained after PEG-ylation was 62.84 +/- 8.2% and further about 82.7% of activity was recovered from the particles. Imitated studies with the native protein confirmed the enhanced stability of the conjugated protein when exposed to the organic solvent and sonication and showed comparatively less encapsulation efficiency due to increased hydrophilicity. Release profiles for native as well as conjugated proteins consisted of sustained release of about 66.66% and 44.45% in 28 days, respectively. The decrease in the release can be attributed to the increase in the molecular weight of the conjugated protein. The study finally proved that PEG-ylation protected the enzyme and prevented it from denaturation during encapsulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22312702

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  7 in total

1.  In vivo imaging of T cells loaded with gold nanoparticles: a pilot study.

Authors:  Hui Li; Laura Diaz; Daniel Lee; Lei Cui; Xin Liang; Yingsheng Cheng
Journal:  Radiol Med       Date:  2013-12-06       Impact factor: 3.469

2.  Immobilization and Characterization of L-Asparaginase over Carbon Xerogels.

Authors:  Rita A M Barros; Raquel O Cristóvão; Sónia A C Carabineiro; Márcia C Neves; Mara G Freire; Joaquim L Faria; Valéria C Santos-Ebinuma; Ana P M Tavares; Cláudia G Silva
Journal:  BioTech (Basel)       Date:  2022-04-14

3.  Implications of designing a bromelain loaded enteric nanoformulation on its stability and anti-inflammatory potential upon oral administration.

Authors:  Manu Sharma; Rishu Sharma
Journal:  RSC Adv       Date:  2018-01-11       Impact factor: 4.036

4.  Recent developments in protein and peptide parenteral delivery approaches.

Authors:  Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Ther Deliv       Date:  2014-03

5.  Development and characterization of a novel l-asparaginase/MWCNT nanobioconjugate.

Authors:  Raquel O Cristóvão; Mafalda R Almeida; Maria A Barros; João C F Nunes; Rui A R Boaventura; José M Loureiro; Joaquim L Faria; Márcia C Neves; Mara G Freire; Valéria C Ebinuma-Santos; Ana P M Tavares; Cláudia G Silva
Journal:  RSC Adv       Date:  2020-08-24       Impact factor: 4.036

Review 6.  Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles.

Authors:  Larissa Pereira Brumano; Francisco Vitor Santos da Silva; Tales Alexandre Costa-Silva; Alexsandra Conceição Apolinário; João Henrique Picado Madalena Santos; Eduardo Krebs Kleingesinds; Gisele Monteiro; Carlota de Oliveira Rangel-Yagui; Brahim Benyahia; Adalberto Pessoa Junior
Journal:  Front Bioeng Biotechnol       Date:  2019-01-10

7.  Superior operational stability of immobilized L-asparaginase over surface-modified carbon nanotubes.

Authors:  Mafalda R Almeida; Raquel O Cristóvão; Maria A Barros; João C F Nunes; Rui A R Boaventura; José M Loureiro; Joaquim L Faria; Márcia C Neves; Mara G Freire; Valéria C Santos-Ebinuma; Ana P M Tavares; Cláudia G Silva
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.